ZUG

WISe.ART Partners with Sustainable Fashion Innovation Society on Upcoming Phygital Sustainability Expo

Retrieved on: 
måndag, juni 3, 2024
WIHN, Internet of things, WKEY, ART, Partnership, Hedera, Cryptocurrency

Rome, Italy – June 3, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, announced that its subsidiary WISe.ART has partnered with Sustainable Fashion Innovation Society (“Society”) on the upcoming Phygital Sustainability Expo® (“Expo”) in Rome, Italy.

Key Points: 
  • Rome, Italy – June 3, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, announced that its subsidiary WISe.ART has partnered with Sustainable Fashion Innovation Society (“Society”) on the upcoming Phygital Sustainability Expo® (“Expo”) in Rome, Italy.
  • In addition to WISe.ART’s partnership, WISeKey’s Cybersecurity and Hedera DePIN (Decentralized Physical Infrastructure Networks) are playing crucial roles in advancing the Phygital Sustainability industry, especially in the realm of sustainable fashion.
  • On the other hand, Hedera DePIN leverages blockchain technology to enhance transparency and traceability within the fashion industry.
  • This integration not only boosts consumer confidence but also encourages brands to adopt more sustainable practices.

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

Retrieved on: 
torsdag, maj 30, 2024
Social Security, Executive Committee, Member, OCS, USD, Calendar, Pully, Compensated emancipation, Financial statement, Annual report, BlackRock, CHF, Proxy, SAB, Executive, Annual general meeting, Management

The Company’s shareholders approved all agenda items, including the election of new members to its Board of Directors.

Key Points: 
  • The Company’s shareholders approved all agenda items, including the election of new members to its Board of Directors.
  • The shareholders approved the 2023 Annual Report including the 2023 Annual (Statutory) Financial Statements and the 2023 Consolidated Financial Statements.
  • The Members of the Board of Directors and the Executive Committee were granted discharge for their activities in 2023.
  • Christina Ackermann, Lionel Carnot, Martijn Kleijwegt, Geraldine O’Keeffe and Riad Sherif were re-elected as members of the Board of Directors.

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Retrieved on: 
onsdag, maj 29, 2024
Therapy, CRISPR Therapeutics, CRSP

ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June.

Key Points: 
  • ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June.
  • A live webcast will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events .
  • A replay of the webcasts will be archived on the Company's website for 14 days following the presentation.

WISeKey International Holding Ltd Announces Agenda Items to be Approved by Shareholders at its 2024 Annual General Meeting

Retrieved on: 
tisdag, maj 28, 2024
WIHN, SIX, WKEY, AGM, Compensated emancipation, Internet of things, Annual report, CHF, Prime Tower

Zug, Switzerland, May 28, 2024 – Ad-Hoc announcement pursuant to Art.

Key Points: 
  • Zug, Switzerland, May 28, 2024 – Ad-Hoc announcement pursuant to Art.
  • 53 of SIX Listing Rules – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, announced today that the Board of Directors has submitted its proposals for shareholder approval at the 2024 Annual General Meeting of Shareholders (“AGM“).
  • It will be possible for shareholders to attend the AGM in person at the venue.
  • Shareholders may also exercise their voting rights by giving electronic or written voting instructions to the independent voting rights representative, as further described in the Company’s invitation to the 2024 AGM published on the date of this press release, or by giving proxy to a representative.

WISeKey Welcomes Confederation’s Decision to Establish the “Swiss Government Cloud” by 2026

Retrieved on: 
tisdag, maj 28, 2024
Cloud, Francs, Crypto, WIHN, Partnership, Cloud storage, Confidentiality, Rot, Flood, Internet of things, Privacy, PKI, Digital, Ecosystem, Federal Council, City, WKEY, Internet, Federation, Trust, Earthquake, Data hub, Root, Cryptocurrency

The system which will be ready for use by early 2026, will also be available to local governmental offices: cantons, cities, and municipalities.

Key Points: 
  • The system which will be ready for use by early 2026, will also be available to local governmental offices: cantons, cities, and municipalities.
  • WISeKey emphasizes Switzerland's potential to establish future-oriented skills that have an impact far beyond its borders and to build international trust.
  • As a concrete measure of support, WISeKey already operates a Swiss-EU-based WISeID Cloud Storage service via www.wiseid.com .
  • A video demonstrating how WISeKey utilizes these unique mountain facilities to meet the highest security standards is available at https://youtu.be/ZKzQvWHZJB4?si=lmBQOOenNmlIj7E6 .

CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments

Retrieved on: 
torsdag, maj 23, 2024
Partnership, Mechanical engineering, Patient, Inflammation, Faculty, Vertex, Rheumatology, Vertex Pharmaceuticals, Princeton University, McGill University, Immunology, McKinsey & Company, Eosinophilic esophagitis, Internal medicine, Therapy, Drug development, CRISPR Therapeutics, MIT, Dermatology, Hemoglobinopathy, Harvard University, NewYork-Presbyterian Hospital, Harvard Medical School, International development, Nursing care plan, Hospital, Chronic obstructive pulmonary disease, Dupilumab, CRISPR, Biotechnology, AstraZeneca, CRSP, NIH, Gastroenterology, Pharmaceutical industry

ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024. Dr. Patel is an experienced drug developer who has worked across a wide range of disease areas, including his most recent leadership role as the Global Development Therapeutic Area Head of Immunology and Inflammation at Sanofi. In addition, the Company also announced the promotion of Julianne Bruno, M.B.A., to Chief Operating Officer, effective as of May 23, 2024. She currently serves as the Company’s Senior Vice President and Head of Programs & Portfolio Management.

Key Points: 
  • “I’m thrilled to welcome a transformational leader of Naimish’s caliber to the executive team at CRISPR Therapeutics,” said Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of CRISPR Therapeutics.
  • Since joining CRISPR Therapeutics in 2019, Julie has been a valuable member of the leadership team and has led several important and impactful cross-functional initiatives including our collaboration with Vertex.
  • Julianne Bruno, M.B.A., has served as Senior Vice President and Head of Programs & Portfolio Management at CRISPR Therapeutics since March 2023.
  • In addition, she has been responsible for program leadership of our immuno-oncology assets and the program management function across our franchises.

WISeKey Shares Key Discussion Points From Its FY 2023 Results Conference Call

Retrieved on: 
tisdag, maj 21, 2024
Constellation, WIHN, Internet of things, Investment, PKI, WKEY, MIT Blackjack Team, Conference, Semiconductor, ART, Growth, Blockchain, LAES, Post-quantum cryptography, Concept, Root, Cryptocurrency

Geneva, Switzerland – May 21, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, shares key discussion points from its FY 2023 Results Conference Call held on May 21, 2024.

Key Points: 
  • Geneva, Switzerland – May 21, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, shares key discussion points from its FY 2023 Results Conference Call held on May 21, 2024.
  • WISeKey operates as a holding company of several distinctive operational companies, each covering a full spectrum of WISeKey-related technologies.
  • Financial Highlights for FY 2023, as compared to FY 2022:
    Revenue growth: A 30% increase in revenue to $31 million.
  • WISeKey has broadened its footprint in the competitive United States market by expanding its sales team and establishing key sales distribution agreements.

WISeKey’s WISeSat.Space is Pioneering IoT Satellite Constellations for Climate Change Monitoring

Retrieved on: 
torsdag, maj 16, 2024
WIHN, Data collection, Flood, Environmental monitoring, Internet of things, Forecasting, Soil, SpaceX, Investment, WKEY, Health, Software as a service, Carbon, Climate change, Weather, AI, Emergency management, Communication, Biodiversity, Policy, LAES, Biomass, Architecture, CO2, Climate, Rotation, Sea, EO, Communications satellite

Geneva, Switzerland – May 16, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company today announced that through its subsidiary WISeSat AG, which focuses on space technology for secure satellite communication, specifically for IoT applications, is pioneering IoT satellite constellations aimed at climate change monitoring.

Key Points: 
  • Geneva, Switzerland – May 16, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company today announced that through its subsidiary WISeSat AG, which focuses on space technology for secure satellite communication, specifically for IoT applications, is pioneering IoT satellite constellations aimed at climate change monitoring.
  • In recent years, space technology has become a critical asset in the global fight against climate change.
  • WISeKey, through its subsidiary WISeSat AG, is at the forefront of this revolution with the creation of an IoT satellite constellation aimed at climate change monitoring and other applications.
  • This innovative approach aims to meet the needs of large IoT deployments in various sectors, including smart farming, energy, climate change monitoring, and logistics.

MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa

Retrieved on: 
torsdag, maj 16, 2024
IL-17A, Patient, University of Miami, Food, European Medicines Agency, Clinical trial, University, Depression, FDA, Associate professor, Moonlake, Single-domain antibody, Inflammation, MIRA, EMA, Tissue, Scar, HS, Pain, VELA, MAS, Pharmaceutical industry

Sonelokimab is designed to directly target sites of inflammation by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers and to penetrate difficult-to-reach inflamed tissues.

Key Points: 
  • Sonelokimab is designed to directly target sites of inflammation by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers and to penetrate difficult-to-reach inflamed tissues.
  • Following the positive results from the landmark Phase 2 MIRA trial, the Phase 3 VELA program is expected to enroll 800 patients across VELA-1 and VELA-2.
  • The Phase 3 program will use a protocol design consistent with the Phase 2 MIRA trial, which identified the optimal dose of sonelokimab for HS.
  • The topline primary endpoint readout (week 16) from the VELA program is expected as of mid-2025.

WISeKey International Holding Ltd Reports Strong Fiscal Year 2023 Financial Results and Provides Updates on Its Strategic Initiatives

Retrieved on: 
onsdag, maj 15, 2024
CyberTrust, WIHN, Security (finance), Partnership, Semiconductor, Web 3.0, Clockseed, QFN, Environmental monitoring, Public key infrastructure, Blockchain, SIX, CFO, SpaceX, Investment, PKI, Ecosystem, Government, WKEY, Digital, Hedera, Internet, Form, Gesellschaft mit beschränkter Haftung, Internet of things, ART, Growth, Research, LAES, NFT, BGA, WLCSP, Agriculture, Cryptocurrency

53 of SIX Listing Rules – WISeKey International Holding Ltd (“WISeKey”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, Semiconductors and Web 3.0 company, today announced its audited financial results for the full year ended December 31, 2023 (“FY 2023”).

Key Points: 
  • 53 of SIX Listing Rules – WISeKey International Holding Ltd (“WISeKey”) (NASDAQ: WKEY; SIX: WIHN), a leading global cybersecurity, Semiconductors and Web 3.0 company, today announced its audited financial results for the full year ended December 31, 2023 (“FY 2023”).
  • This positive change is primarily due to the disposal of the loss-making subsidiary, arago GmbH, completed in 2022, alongside strategic cost management initiatives.
  • Carlos Moreira, Chairman and CEO of WISeKey, stated, "Our solid results in 2023 are a demonstration of our sound business strategy, growth initiatives and strategic investments we made during the year.
  • Peter Ward, CFO of WISeKey, added, "Focused execution and operating discipline were key drivers of our strong results in 2023.